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Abstract
Objectives To review the computed tomography (CT)
findings of common and uncommon high-attenuation
pulmonary lesions and to present a classification scheme
of the various entities that can result in high-attenuation
pulmonary abnormalities based on the pattern and distribu-
tion of findings on CT.
Background High-attenuation pulmonary abnormalities can
result from the deposition of calcium or, less commonly,
other high-attenuation material such as talc, amiodarone,
iron, tin, mercury and barium sulphate. CT is highly
sensitive in the detection of areas of abnormally high
attenuation in the lung parenchyma, airways, mediastinum
and pleura. The cause of the calcifications and other high-
attenuation conditions may be determined based on the
location and pattern of the abnormalities within the lung
parenchyma and knowledge of the associated clinical
features.
Results We have presented a diagnostic approach based on
the presence and distribution of five main patterns of high-
attenuation conditions on CT: (1) small hyperdense nodules,
(2) large calcified nodules or masses, (3) high-attenuation
linear or reticular pattern, (4) high-attenuation consolidation
and (5) high attenuation extraparenchymal lesions.
Conclusions Some high-attenuation pulmonary abnormali-
ties have characteristic CT findings suggesting the correct
diagnosis. In other diseases, a combination of clinical
features and radiological findings can significantly improve
diagnostic accuracy.
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Introduction
High-attenuation pulmonary abnormalities can result from a
variety of different conditions, including from the deposi-
tion of calcium. Amiodarone pulmonary toxicity may cause
high-attenuation pulmonary parenchymal opacities. Multi-
ple dense nodular opacities are rarely seen in siderosis,
stannosis, talcosis and baritosis, in which iron, tin, talc and
barium sulfate respectively are deposited in the lungs.
Computed tomography (CT) is highly sensitive in the
detection of areas of abnormally high attenuation in the
lung parenchyma, airways, mediastinum and pleura. Calci-
fications in the thorax are frequently manifestations of
previous infectious processes. However, they may be due to
benign or malign neoplasms, metabolic disorders, or
occupational exposure. The cause of the calcifications and
other high-attenuation conditions may be determined by
means of the location and pattern of the abnormalities
within the lung parenchyma and knowledge of the associated
clinical features. High-attenuation pulmonary abnormalities
can be divided into five main patterns on CT: small
hyperdense nodules, large nodules or masses, high-
attenuation linear or reticular pattern, high-attenuation con-
solidation, and high-attenuation extraparenchymal lesions.
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Small hyperdense nodules
Small hyperdense nodules are nodular opacities measuring
less than 10 mm in diameter, showing focal or diffuse
distribution in the lung parenchyma. Small hyperdense
nodules can be secondary to dystrophic calcification in
previously damaged lung parenchyma. Small calcified
parenchymal nodules most commonly are a result of
infectious diseases. Other causes of small hyperdense
nodules are pulmonary metastases, chronic haemorrhagic
conditions, occupational diseases, deposition diseases,
talcosis and idiopathic disorders such as pulmonary alveolar
microlithiasis [1–3].
Fig. 1 Residual postprimary pulmonary tuberculosis. Axial CT shows
calcified granulomatous nodules in the left upper lobe (long arrows).
Calcified nodules and the sequelae of parenchymal changes are also
seen in the right upper lobe (short arrows)
Fig. 2 Metastatic pulmonary calcification in a 24-year-old man who
had known chronic renal failure. Axial CT at a mediastinal and b
parenchymal windows demonstrates bilateral centrilobular fluffy
ground-glass nodular opacities that contain foci of calcification
(arrows)
Fig. 3 Silicosis. Axial CT at the mediastinal window shows multiple
calcified nodules with a conglomerate mass of fibrosis in the upper
lobes (arrows)
Fig. 4 Barium aspiration. Axial CT at a mediastinal and b
parenchymal windows shows extremely dense opacities in both lower
lobes (arrows)
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Calcified parenchymal nodules are frequently seen in
tuberculosis. The sequela dystrophic calcification follows
caseation, necrosis or fibrosis. These nodules are seen as
well circumscribed parenchymal calcifications with fibrosis
on CT (Fig. 1). Most patients with pulmonary nodular
calcifications secondary to tuberculosis have calcified hilar
or mediastinal lymph nodes, known together as the Ranke
complex. Histoplasmosis and varicella infections may less
commonly lead to parenchymal calcified nodules [1].
Widespread micronodular calcification can be seen in the
late period of varicella infection.
Metastatic pulmonary calcification is a consequence of
calcium deposition in normal pulmonary parenchyma. This
condition can occur in a variety of benign and malignant
disorders such as primary and secondary hyperparathyroid-
ism, chronic renal failure, sarcoidosis, vitamin D intoxica-
tion, IV calcium therapy, multiple myeloma and massive
osteolysis caused by metastases [4]. High-resolution CT
(HRCT) findings are characterised by centrilobular fluffy
ground-glass nodular opacities that contain foci of calcifi-
cation (Fig. 2). Metastatic pulmonary calcification is
typically most marked in the upper lobes.
Idiopathic pulmonary haemosiderosis is an uncommon
cause of alveolar haemorrhage that occurs predominantly in
infants and young adults. This disorder is characterised by
Fig. 5 Pulmonary alveolar microlithiasis. Axial CT at a mediastinal
and b parenchymal windows shows diffuse numerous dense micro-
nodules with calcified thickening of interlobular septa and subpleural
cysts
Fig. 6 Hamartomas. Axial CT shows popcorn calcification in a
benign solitary pulmonary nodule (arrow)
Fig. 8 Metastatic osteosarcoma. Axial CT shows parenchymal and
pleural calcified metastatic lesions in both haemothoraces (arrows)
Fig. 7 Lung carcinoma. Axial CT shows eccentric calcification in a
malignant mass, invading the mediastinum and right hilar region
(arrows)
Insights Imaging (2010) 1:287–292 289
recurrent episodes of alveolar haemorrhage. HRCT shows
dense centrilobular nodular opacities due to recurrent
haemorrhage. Secondary haemosiderosis due to mitral
stenosis may present with small calcified nodules.
Diffuse small calcified nodules, often associated with
egg-shell calcification of hilar or mediastinal lymph nodes,
can occur in silicosis and coal workers’ pneumoconiosis.
Silicosis is caused by inhalation of free silica particles,
usually during occupational exposure such as mining,
sandblasting and masonry. Radiographic evidence of
silicosis typically develops after 10–20 years of exposure
to low concentrations of silica dust [5]. HRCT findings of
silicosis include diffuse and randomly distributed small
well-defined nodules that are most prominent in the upper
lobes [6]. These calcified nodules are commonly seen with
massive fibrosis (Fig. 3).
Multiple dense nodular opacities are rarely seen in
siderosis, stannosis and baritosis, in which iron, tin and
barium respectively are deposited in the lungs. In siderosis,
nodular opacities are less dense and less profuse than those
in silicosis. HRCT shows extremely dense opacities due to
barium aspiration in baritosis, usually locating in the basal
segments of the lower lobes (Fig. 4).
Alveolar microlithiasis, a rare disease of unknown
origin, is characterized by diffuse sand-like calcifications
within the alveoli. This disorder may be detected inciden-
tally on chest radiographs obtained for other reasons.
Characteristic HRCT findings consist of multiple innumerable
Fig. 9 Mucus plugging. Axial CT (lung window) shows calcified
linear bronchial opacity in the right upper lobe (arrow)
Fig. 10 Amiodarone toxicity. Axial unenhanced CT at a mediastinal
and b parenchymal windows shows dense lung consolidations in both
lower lobes (arrows). Bilateral pleural effusion and pericardial
effusion are also seen
Fig. 11 Calcified atelectasis. Axial unenhanced CT at the mediastinal
window shows high-attenuation consolidations in both upper lobes
(arrows)
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tiny sand-like calcified micronodules that tendency toward
confluence throughout both lungs. Other findings include
calcified interlobular septa and small subpleural cysts.
Another feature seen on HRCT includes a very low
attenuation line alongside the pleura, called the “black pleural
line” (Fig. 5).
Talcosis is seen in workers exposed to talc during
extraction of magnesium silicate from mines and grinding.
Another form of talcosis can be seen in drug users who
inject talc. When dissolved and injected intravenously, talc
particles become deposited within pulmonary arterioles,
capillaries and interstitium.
HRCT findings consist of numerous high-attenuation
well-defined micronodules or diffuse ground-glass opaci-
ties. Over time the nodules tend to confluence, resulting in
high-attenuation confluent masses.
Large calcified nodules or masses
Calcification can be seen in a variety of benign and malignant
tumours such as hamartomas, chondromas, plasmocytomas,
carcinoid tumours and bronchial carcinomas [7]. Hamartoma
is the most common benign tumour of the lung. Calcification
can be detected on CT in over 30% of cases. Hamartomas
have characteristic popcorn-like or diffuse calcification
(Fig. 6). Bronchogenic carcinoma may rarely contain
calcification, usually eccentric in location (Fig. 7). Calcifi-
cation within tumours occurs by three mechanisms: (1)
calcified scar tissue or granulomatous disease engulfed by
tumour, (2) dystrophic calcification within areas of tumour
necrosis and (3) calcium deposition within the tumour as a
result of the secretory function of the carcinoma itself.
Calcification in pulmonary metastases is rare and can
result from either sarcomas (osteosarcomas, chondrosarco-
mas and synovial sarcomas) or carcinomas (mucin-producing
carcinomas, thyroid carcinomas and treated metastatic
choriocarcinomas). Osteosarcoma may lead to multiple,
calcified parenchymal and pleural metastases (Fig. 8). Bone
Fig. 13 Pleural calcification secondary to empyema. Axial CT shows
pleural calcification at the right haemothorax (arrow)
Fig. 12 Endobronchial teeth secondary to trauma. Axial CT (bone
window) demonstrates teeth in the right main and upper lobe bronchus
(arrows)
Fig. 15 Lymph node calcification. Axial CT shows right paratracheal
calcified lymph nodes secondary to tuberculosis (arrow)
Fig. 14 Empyema necessitans after tuberculous empyema. Axial CT
shows a calcified pleural mass, extending the extrapleural structures at
the right haemothorax (arrows)
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formation in osteoid tumour, calcification and ossification of
tumour cartilage, dystrophic calcification and mucoid calci-
fication are mechanisms responsible for calcification in
metastases.
Parenchymal calcified nodules or consolidation may be
seen in pulmonary amyloidosis.
High-attenuation linear or reticular pattern
Diffuse pulmonary ossification is an uncommon condition
that is characterised by metaplastic bone formation in the
lung parenchyma. It is associated with a variety of
pulmonary, cardiac and systemic disorders. It may be
localised or distributed widely [8].
Linear calcification through the lung interstitium is
occasionally seen in idiopathic pulmonary fibrosis.
Long-standing mucus plugging may progress to linear or
nodular calcification (Fig. 9).
High-attenuation consolidation
Deposition of iodine can occur within the lung parenchyma
as a result of treatment with amiodarone, a tri-iodinated
anti-arrhythmic drug. Pulmonary toxicity occurs in 2–18%
of patients [3]. The most common CT findings include
septal thickening, interstitial fibrosis and high attenuation
consolidations (Fig. 10). The association of dense lung air-
space consolidations with a high density of the liver and
spleen is characteristic of amiodarone exposure.
Chronic atelectasis can be rarely seen as calcified
consolidation (Fig. 11).
High-attenuation extraparenchymal lesions
Aspiration of teeth or dental fragments may be seen after
trauma. CT shows high-attenuation endobronchial lesions
(Fig. 12).
Pleural calcification occurs most often as the result of
long-standing inflammatory diseases, such as empyema,
haemothorax or tuberculosis (Fig. 13). Pleural calcification
is also a common manifestation of asbestos exposure [9].
Empyema necessitans is a rare complication of pleural
space infections and occurs when the infected fluid dissects
spontaneously into the chest wall from the pleural space
[10]. Tuberculosis is more likely than pyogenic organisms
to form an empyema necessitans (Fig. 14).
Lymph node calcifications result from healed granulo-
matous infection, usually tuberculosis or histoplasmosis
(Fig. 15). Eggshell calcification is highly suggestive of
silicosis or coal workers' pneumoconiosis, but it has also
been described in sarcoidosis, Hodgkin's disease and
infections such as histoplasmosis or blastomycosis.
Conclusions
Some high-attenuation pulmonary abnormalities have char-
acteristic CT findings suggesting the correct diagnosis. In
other diseases, a combination of clinical features and
radiological findings can significantly improve diagnostic
accuracy.
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